Mobile Stroke Unit Market Report Scope & Overview:

The Mobile Stroke Unit Market was valued at USD 39.50 Million in 2025 and is expected to reach USD 68.11 Million by 2035, growing at a CAGR of 5.60% from 2026-2035.

Stroke centers and emergency medical systems are deploying specially equipped ambulances that bring a computed tomography scanner and a vascular neurologist to the patient, compressing the time between symptom onset and treatment. Computed tomography scanner equipment remains the largest component because on-board imaging lets paramedics confirm a stroke diagnosis and rule out hemorrhage before hospital arrival. Telemedicine systems are growing fastest as remote neurologist consultation lets smaller hospital systems operate a unit without staffing an on-board physician around the clock. North America holds 46.50% share in 2025, while Asia Pacific expands fastest at a CAGR near 8.70% from 2026 to 2035 as regional systems pilot their first dedicated stroke ambulances.

⮞In September 2026, Ascension Sacred Heart launched Northwest Florida's first mobile stroke unit, an emergency department on wheels with on-board imaging that serves North Walton County and surrounding rural communities.

Mobile Stroke Unit Market Trends

  • Hospital systems are increasingly packaging artificial-intelligence-assisted triage software directly into on-board CT imaging workflows.

  • Public-private partnership funding models are expanding beyond major academic centers into mid-sized regional hospital systems.

  • Vehicle manufacturers are standardizing van-based conversion processes to shorten delivery timelines for new unit orders.

  • Emergency medical services agencies are piloting dedicated dispatch protocols that route suspected stroke calls directly to available units.

  • Telemedicine-based staffing models are becoming a meaningful entry point for hospital systems unable to staff an on-board neurologist continuously.

U.S. Mobile Stroke Unit Market Outlook

The U.S. Mobile Stroke Unit Market was valued at USD 16.90 Million in 2025 and is expected to reach USD 27.26 Million by 2035, growing at a CAGR of 4.90% from 2026-2035.

U.S. demand is anchored by a growing number of comprehensive stroke centers that already treat a dedicated mobile stroke unit as a standard extension of their emergency stroke protocol rather than a pilot program. Academic medical centers and large urban hospital systems operate the broadest share of active units, giving manufacturers a concentrated and well-funded buyer base to design around. Emergency medical services agencies increasingly co-fund unit deployment with partner hospitals, widening the addressable buyer base beyond hospital systems acting alone. U.S.-based manufacturers continue expanding vehicle and on-board imaging production capacity to meet this shift, keeping the United States the largest single market within North America through the forecast period.

⮞In May 2026, UCLA Health, in collaboration with Siemens Healthineers, performed the world's first ambulance-based brain perfusion scan, advancing pre-hospital stroke imaging and enabling faster treatment decisions.

Mobile Stroke Unit Market Segment Analysis

  • By Component, the Computed Tomography Scanner segment dominated the Mobile Stroke Unit Market with approximately 38.50% share in 2025, while the Telemedicine System segment is the fastest growing with a CAGR of approximately 7.20%.

  • By Ownership Model, the Hospital-Owned Fleets segment dominated the Mobile Stroke Unit Market with approximately 54.60% share in 2025, while the Public-Private Partnership Fleets segment is the fastest growing with a CAGR of approximately 6.80%.

  • By End User, the Hospitals segment dominated the Mobile Stroke Unit Market with approximately 56.50% share in 2025, while the Emergency Medical Services Providers segment is the fastest growing with a CAGR of approximately 7.60%.

  • By Vehicle Type, the Van-Based Units segment dominated the Mobile Stroke Unit Market with approximately 61.50% share in 2025, while the Trailer & Container-Based Units segment is the fastest growing with a CAGR of approximately 6.90%.

By Component, Computed Tomography Scanner Dominates the Mobile Stroke Unit Market and Telemedicine System Grows Fastest

Computed tomography scanner equipment holds the largest component share because confirming a stroke diagnosis and ruling out hemorrhage before hospital arrival is the entire clinical rationale for operating a mobile stroke unit in the first place. Hospital systems specify on-board CT scanning specifically to enable pre-hospital clot-dissolving treatment decisions that cannot safely be made on clinical judgment alone. Equipment vendors continue miniaturizing head CT scanners specifically to fit within standard ambulance chassis dimensions without compromising image quality. That combination of clinical necessity and continued equipment miniaturization keeps computed tomography scanners the dominant component across nearly every operating mobile stroke unit today.

Telemedicine systems are growing fastest as remote neurologist consultation lets hospital systems operate a unit without staffing a vascular neurologist on board around the clock, a staffing model few systems outside major academic centers can sustain. Vendors are packaging high-bandwidth video and diagnostic-image transmission specifically for the connectivity constraints of a moving vehicle. Smaller and mid-sized hospital systems are increasingly specifying telemedicine-based operating models as their entry point into stroke ambulance deployment. As more systems adopt remote-neurologist staffing models to control operating cost, telemedicine systems are expected to keep growing faster than the broader component category through 2035.

By Ownership Model, Hospital-Owned Fleets Dominate the Mobile Stroke Unit Market and Public-Private Partnership Fleets Grow Fastest

Hospital-owned fleets hold the largest ownership-model share because academic medical centers and large health systems have the capital base and clinical staff depth to operate a unit as a direct extension of their own stroke program. These systems benefit from integrating unit data directly into their existing electronic health record and quality-reporting infrastructure without a third-party intermediary. Hospital systems also capture the full philanthropic and grant funding associated with unit deployment rather than sharing it with an outside partner. That combination of clinical integration and funding capture keeps hospital-owned fleets the dominant ownership model across the category today.

Public-private partnership fleets are growing fastest as hospital systems increasingly share capital and operating cost with municipal emergency medical services agencies or private ambulance operators rather than funding a unit entirely on their own. This model lets a smaller hospital system access mobile stroke unit capability without bearing the full seven-figure capital cost of vehicle and imaging equipment alone. Municipal EMS agencies benefit from this arrangement by extending their own stroke-response capability without directly employing additional neurology staff. As more mid-sized systems pursue shared-cost deployment models, public-private partnership fleets are expected to keep growing faster than the broader ownership-model category through 2035.

⮞Cleveland Clinic, which launched its mobile stroke unit in 2014, marked ten years of hospital-owned operation in 2024.

By End User, Hospitals Dominate the Mobile Stroke Unit Market and Emergency Medical Services Providers Grow Fastest

Hospitals remain the dominant end user because operating a mobile stroke unit requires direct integration with an existing comprehensive stroke center's clinical staff, imaging protocols and treatment pathways. Health systems view unit deployment as a natural extension of their existing stroke program rather than a standalone service line requiring separate infrastructure. Philanthropic donors and research grants increasingly target hospital-based programs specifically, reinforcing hospitals' funding advantage relative to other potential operators. That combination of clinical integration and funding access keeps hospitals the dominant end user across the category today.

Emergency medical services providers are growing fastest as municipal EMS agencies increasingly co-operate units alongside hospital partners rather than leaving stroke ambulance deployment entirely to health systems. EMS agencies bring pre-existing dispatch infrastructure and trained paramedic staff that materially lowers the incremental cost of adding stroke-specific capability to their fleet. Several metropolitan EMS systems are piloting dedicated stroke-response protocols that route suspected stroke calls directly to a mobile stroke unit ahead of a standard ambulance. As more metropolitan EMS agencies pursue this co-operating model, this end-user category is expected to keep growing faster than the broader segment through 2035.

⮞In January 2026, the American Heart Association and American Stroke Association published their 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke, which gives mobile stroke units a Class 1, Level A recommendation over conventional EMS for patients eligible for thrombolysis, according to Frazer's summary of the guideline.

By Vehicle Type, Van-Based Units Dominate the Mobile Stroke Unit Market and Trailer & Container-Based Units Grow Fastest

Van-based units remain the dominant vehicle type because a standard ambulance-style van chassis offers the simplest and most cost-effective platform for housing a CT scanner, telemedicine equipment and point-of-care laboratory capability together. Vehicle manufacturers have standardized van-based conversion processes specifically around this vehicle type, shortening delivery timelines relative to custom builds. Hospital systems favor van-based units for their compatibility with existing ambulance maintenance and staffing infrastructure already in place. That combination of conversion simplicity and operational compatibility keeps van-based units the dominant vehicle type across the category today.

Trailer and container-based units are growing fastest as some health systems explore stationary or semi-mobile deployment models for high-volume urban areas where a unit can be positioned near a predictable cluster of emergency calls. These formats can house larger imaging equipment than a van chassis typically allows, broadening the clinical capability available on site. Manufacturers are piloting modular container designs specifically to support this emerging deployment pattern in dense urban environments. As health systems continue experimenting with positioned rather than continuously roving deployment models, this vehicle type is expected to keep growing faster than the broader category through 2035.

Regional Analysis

Region

Major Country

Share within Region, 2025 (%)

North America

United States

92.37%

Europe

Germany

24.68%

Asia Pacific

Australia

30.42%

Latin America

Brazil

46.73%

Middle East and Africa

United Arab Emirates

34.26%

North America Mobile Stroke Unit Market Insights

Holding a 46.50% share in 2025, North America leads the market on the strength of its large base of comprehensive stroke centers and well-established philanthropic funding channels for emergency medical equipment. The United States supplies 92.00% of regional output, anchored by major academic medical centers and large urban hospital systems operating the broadest share of active units. Canada contributes a smaller but steady share, supported by stroke programs at major academic hospitals pursuing similar deployment models. That combination of funding access and clinical infrastructure keeps North America the largest region despite faster growth concentrating in newer markets elsewhere.

Philanthropic donations and research grants continue funding a large share of new unit deployments across major U.S. academic medical centers, reducing reliance on direct hospital capital budgets alone. Emergency medical services agencies across several metropolitan areas continue co-funding units with hospital partners, broadening the regional deployment base beyond hospital-only ownership models. Professional medical societies continue publishing updated clinical guidance incorporating mobile stroke units into standard emergency stroke protocols. As funding access and clinical guidance continue reinforcing each other, North America is expected to remain a leading market through most of the forecast period to 2035.

⮞UCLA Health received a USD 6 million donation from the Brett-Torino Foundation in 2025 to expand its Mobile Stroke Rescue Program fleet across the Los Angeles metropolitan area.

Europe Mobile Stroke Unit Market Insights

Europe's market is anchored by a cluster of academic medical centers in Germany and neighboring countries that pioneered early mobile stroke unit research and clinical protocol development. Germany anchors regional demand through its long-running academic stroke ambulance research programs feeding directly into continued fleet expansion. The United Kingdom and other Western European markets contribute additional demand as national health systems evaluate pilot deployments informed by Germany's longer operating track record. That combination of research leadership and pilot-program expansion keeps Europe an important region relative to its moderate percentage growth outlook through the forecast period.

Unlike in the United States, where philanthropy often covers the vehicle, most European units depend on regional hospital budgets or statutory health insurers, which makes each new deployment a separate funding negotiation. Germany's B_PROUD trial, published in JAMA in 2021 and run from Berlin, compared mobile stroke unit dispatch with conventional ambulance care and gave payers elsewhere a concrete reference when weighing the cost of a unit. Because every country reimburses prehospital care differently, programs that succeed in one market rarely transfer directly to another. As a result, Europe is expected to stay an influential but more measured market through 2035.

Asia Pacific Mobile Stroke Unit Market Insights

Asia Pacific is the fastest-growing region, projected to expand at a CAGR of approximately 8.70% from 2026 to 2035, as Australia, Japan and other regional health systems launch their first dedicated stroke ambulances following encouraging international clinical outcome data. Australia anchors recent regional momentum, with state health systems funding new dedicated stroke ambulances alongside existing emergency response fleets. Japan and South Korea continue evaluating pilot deployments informed by both European and North American operating experience. That combination of new program launches and favorable outcome evidence gives Asia Pacific the fastest expansion trajectory among all regions.

Many Asia Pacific programs import a complete vehicle-and-scanner package from a European or North American supplier rather than building conversion capability locally, which speeds setup but ties early units to long shipping and service lead times. State and national health agencies typically fund the first units as pilots, with local door-to-treatment and disability outcomes serving as the test for larger fleet orders. Private hospital networks in large cities with long ambulance transport times are also exploring units as a premium emergency-care offering. If pilots confirm the benefit seen elsewhere, the region's share of global demand is expected to keep rising through 2035.

⮞Royal Melbourne Hospital and Monash Health launched Australia's second dedicated stroke ambulance in Melbourne in January 2025, expanding advanced pre-hospital stroke treatment coverage across Victoria.

MEA & Latin America Mobile Stroke Unit Market Insights

The Middle East and Africa region remains a comparatively small but emerging mobile stroke unit market, with the United Arab Emirates accounting for the largest regional share on the strength of its well-funded hospital network and growing investment in advanced emergency care infrastructure. Saudi Arabia contributes additional demand as national health investment programs fund advanced emergency medical equipment across major metropolitan hospital systems. South Africa anchors interest across the African continent, supported by a handful of major private hospital networks evaluating pilot deployment. Elsewhere in the region, most markets have yet to deploy a dedicated unit, relying instead on standard emergency transport to hospital-based stroke centers.

Latin America's mobile stroke unit market remains nascent, with Brazil accounting for the largest regional interest on the strength of its large private hospital network and several academic medical centers evaluating pilot programs. Mexico contributes additional interest tied to private hospital systems serving urban metropolitan areas near the U.S. border. Capital cost remains the primary barrier to broader regional adoption, as few health systems outside the largest private networks can fund a unit without external grant or philanthropic support. Even so, growing awareness of international outcome data is expected to support gradual regional adoption through most of the forecast period to 2035.

Market Dynamics

Growth Drivers: Clinical outcome evidence and equipment miniaturization are lifting global demand

Clinical outcome data from early-adopter programs continues demonstrating meaningfully faster treatment times and improved functional recovery for stroke patients treated on board a mobile stroke unit rather than transported directly to a hospital. Professional medical societies are increasingly incorporating this evidence into updated clinical guidance, formally recognizing mobile stroke units within standard emergency stroke protocols. Hospital systems citing this evidence are finding it easier to secure philanthropic and grant funding for new unit deployment. Together these forces are expanding the addressable market across a broader range of hospital systems than in prior years.

A second driver is continued miniaturization of on-board imaging and diagnostic equipment, letting manufacturers fit increasingly capable computed tomography and point-of-care laboratory systems within standard ambulance-sized vehicle chassis. Equipment vendors are packaging artificial-intelligence-assisted triage software directly into on-board imaging systems to speed treatment decisions in the field. Vehicle manufacturers are standardizing conversion processes specifically to shorten delivery timelines for hospital systems ordering new units. As onboard equipment capability continues advancing, this trend is expected to keep broadening mobile stroke unit demand through 2035.

⮞In March 2026, Northwestern added a mobile stroke unit equipped with a 32-slice CT scanner, which it said halves imaging time compared with a 16-slice model and cut time to treatment from 83 to 47 minutes.

Restraints: High capital cost and reimbursement uncertainty slow broader adoption

High upfront capital cost continues restricting broader adoption, since a single fully equipped unit typically requires a multi-million-dollar investment in vehicle conversion and on-board imaging equipment before any treatment revenue begins. Systems without philanthropic or grant funding often have to run a multi-year fundraising campaign before ordering a vehicle, which delays or cancels deployment. Smaller and mid-sized health systems in particular struggle to justify this outlay against uncertain utilization volume in less densely populated service areas, and the pressure is greatest outside major metropolitan markets.

Reimbursement uncertainty also constrains broader adoption, as billing codes and payer coverage policies for on-board imaging and treatment services remain inconsistently defined across different insurance programs and government health systems. Without clear billing rules, hospitals must either absorb uncompensated operating cost or confine units to areas with a favorable payer mix. Policy uncertainty adds further planning difficulty for systems evaluating multi-year capital commitments, and together with capital cost it is the category's most persistent restraint beyond well-funded academic medical centers.

Opportunities: AI-assisted triage and partnership-financing models open new revenue paths

Investment in artificial-intelligence-assisted stroke imaging software is accelerating as developers seek to speed on-board treatment decisions and extend specialist-level triage capability to hospital systems without dedicated neuroradiology staff available around the clock. Companies that secure regulatory clearance and clinical validation for these tools are positioned to capture share from manufacturers still reliant entirely on standard imaging workflows. Hospital systems evaluating new unit deployment increasingly request AI-assisted triage capability as a standard equipment specification rather than an optional upgrade. That combination of regulatory progress and buyer demand gives well-capitalized AI-imaging developers a credible path to meaningful share over the next decade.

A second opportunity lies in public-private partnership deployment models, where hospital systems share capital and operating cost with municipal emergency medical services agencies or private ambulance operators to extend unit coverage into previously underserved service areas. Vehicle and equipment manufacturers that develop flexible financing and shared-ownership structures are capturing new hospital-system customers faster than competitors requiring full upfront capital payment. Municipal governments in several metropolitan areas are beginning to explore co-funding arrangements as part of broader emergency-response modernization initiatives. Companies that deepen these partnership-financing relationships are positioned to capture growth that traditional hospital-only sales models alone will likely cede.

⮞Brainomix raised USD 18 million in a Series C funding round in March 2025 to expand its AI-powered stroke imaging platform into the United States market.

Recent Developments:

  • In March 2026, Northwestern deployed a new mobile stroke unit equipped with a 32-slice CT scanner, reporting that more than 500 patients were treated in 2025 and that time to treatment fell from 83 to 47 minutes.

  • In May 2025, Siemens Healthineers announced the first U.S. mobile stroke unit equipped with its Somatom On.site head CT scanner at UCLA Health. The deployment expanded access to pre-hospital brain imaging and supported faster stroke diagnosis and treatment decisions.

  • In September 2026, Ascension Sacred Heart launched Northwest Florida's first mobile stroke unit, bringing specialized on-board imaging to North Walton County and surrounding rural communities.

  • In February 2025, Brainomix partnered with Medtronic Neurovascular to expand AI-powered stroke imaging adoption across Western Europe. The collaboration combines Brainomix 360 Stroke software with Medtronic's neurovascular expertise to improve diagnostic decisions and access to thrombectomy treatment.

Mobile Stroke Unit Market Key Players

  • Siemens Healthineers AG

  • NeuroLogica Corp. (Samsung Electronics)

  • Frazer, Ltd.

  • Demers Ambulances

  • MEYTEC GmbH

  • RMA Special Vehicles

  • Tri-Star Industries Limited

  • Brainomix Limited

  • WAS Wietmarscher Ambulanz- und Sonderfahrzeug GmbH

  • Excellance, Inc.

  • RapidAI

Mobile Stroke Unit Market Report Scope:

Report Attributes Details
Market Size in 2025 USD 39.50 Million
Market Size by 2035 USD 68.11 Million
CAGR CAGR of 5.60% From 2026 to 2035
Base Year 2025
Forecast Period 2026-2035
Historical Data 2022-2024
Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Component (Computed Tomography Scanner, Telemedicine System, Conventional Emergency Equipment, Point-of-Care Laboratory Systems)
• By Ownership Model (Hospital-Owned Fleets, Public-Private Partnership Fleets, Government/EMS-Owned Fleets)
• By End User (Hospitals, Emergency Medical Services Providers, Academic & Research Institutes)
• By Vehicle Type (Van-Based Units, Trailer & Container-Based Units)
Regional Analysis/Coverage North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America).
Company Profiles Siemens Healthineers AG, NeuroLogica Corp. (Samsung Electronics), Frazer, Ltd., Demers Ambulances, MEYTEC GmbH, RMA Special Vehicles, Tri-Star Industries Limited, Brainomix Limited, WAS Wietmarscher Ambulanz- und Sonderfahrzeug GmbH, Excellance, Inc., RapidAI